These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16373038)

  • 21. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 22. [Statins: from data to routine prescription…].
    Vital Durand D
    Rev Med Interne; 2014 Mar; 35(3):151-3. PubMed ID: 24314846
    [No Abstract]   [Full Text] [Related]  

  • 23. [Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?].
    Albert Fàbregas L; González-Clemente JM
    Med Clin (Barc); 2014 Apr; 142(8):358-9. PubMed ID: 24602748
    [No Abstract]   [Full Text] [Related]  

  • 24. Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence.
    Davidson MH
    J Clin Lipidol; 2010; 4(1):72-3; discussion 74. PubMed ID: 21122630
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point: Low-density lipoprotein cholesterol goals in patients with diabetes are not adequately based on evidence.
    Gosmanov AR
    J Clin Lipidol; 2010; 4(1):69-71; discussion 74. PubMed ID: 21122629
    [No Abstract]   [Full Text] [Related]  

  • 27. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
    Paulo S; Fernandes S; Vizinho R; Carneiro AV
    Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Improvement in cardiovascular prognosis of type 2 diabetes mellitus, is it a reality?].
    Ruiz-Hurtado G; Vigil L; Ruilope LM
    Hipertens Riesgo Vasc; 2016; 33(4):123-125. PubMed ID: 27770841
    [No Abstract]   [Full Text] [Related]  

  • 29. Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.
    Udell JA; Scirica BM; Braunwald E; Raz I; Steg PG; Davidson J; Hirshberg B; Bhatt DL
    Clin Cardiol; 2012 Dec; 35(12):722-9. PubMed ID: 22760763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
    Pérez A
    Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH
    Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [About cardiovascular risk assessment in the new clinical trials with statins].
    Martín Luján F; Baldrich Justel M; Solà Alberich R; Basora Gallisà J
    Med Clin (Barc); 2004 Apr; 122(14):559. PubMed ID: 15117656
    [No Abstract]   [Full Text] [Related]  

  • 34. Miracle or mirage?
    Learner S
    Nurs Stand; 2007 Aug 1-7; 21(47):18-20. PubMed ID: 17824448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins for patients with type 2 diabetes.
    Pimpinella G; Bertini Malgarini R; Martini N
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1933; author reply 1933. PubMed ID: 15566999
    [No Abstract]   [Full Text] [Related]  

  • 36. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal Prescribing of Statins to Reduce Cardiovascular Disease.
    Schade DS; Duro T; Eaton RP
    Am J Med; 2023 Dec; 136(12):1133-1135. PubMed ID: 37572739
    [No Abstract]   [Full Text] [Related]  

  • 38. [Not Available].
    Bilz S
    Ther Umsch; 2017; 74(8):445-453. PubMed ID: 29461147
    [No Abstract]   [Full Text] [Related]  

  • 39. Contrast-induced acute kidney injury in diabetes mellitus: Clinical relevance and predisposing factors. Could statins be of benefit?
    Katsiki N; Fonseca V; Mikhailidis DP
    J Diabetes Complications; 2018 Nov; 32(11):982-984. PubMed ID: 30131213
    [No Abstract]   [Full Text] [Related]  

  • 40. Should rheumatologists prescribe statins?
    Soubrier M; Bruckert E
    Joint Bone Spine; 2010 Mar; 77(2):93-5. PubMed ID: 20207572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.